Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas

Brian Schulte, Nisha Mohindra, Mohammed Milhem, Steven Attia, Steven Robinson, Varun Monga, Angela C. Hirbe, Peter Oppelt, John Charlson, Irene Helenowski, Susan Abbinanti, Rasima Cehic, Scott Okuno, Brian A. Van Tine, Mark Agulnik*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science